Founded in 2018, Beijing Qihengxing Biotechnology Co., Ltd. is a national high-tech enterprise with multiple invention patents. Leveraging core technology platforms, including proprietary enzyme engineering platforms, PCR/qPCR systems, nucleic acid extraction platforms, and NGS platforms, the company has developed numerous high-quality products for diverse applications, including molecular biology, NGS applications, and synthetic biology. The company also offers a platform for technical and prac
Dec 5th,2024951 Views
Congratulations to Qihengxing for being awarded Zhongguancun High-tech Enterprise
